The first clinical implementation of real-time 6 degree-of-freedom image-guided radiotherapy for liver SABR patients.

PURPOSE: Multiple survey results have identified a demand for improved motion management for liver cancer IGRT. Until now, real-time IGRT for liver has been the domain of dedicated and expensive cancer radiotherapy systems. The purpose of this study was to clinically implement and characterise the performance of a novel real-time 6 degree-of-freedom (DoF) IGRT system, Kilovoltage Intrafraction Monitoring (KIM) for liver SABR patients. METHODS/MATERIALS: The KIM technology segmented gold fiducial markers in intra-fraction x-ray images as a surrogate for the liver tumour and converted the 2D segmented marker positions into a real-time 6DoF tumour position. Fifteen liver SABR patients were recruited and treated with KIM combined with external surrogate guidance at three radiotherapy centres in the TROG 17.03 LARK multi-institutional prospective clinical trial. Patients were either treated in breath-hold or in free breathing using the gating method. The KIM localisation accuracy and dosimetric accuracy achieved with KIM + external surrogate were measured and the results were compared to those with the estimated external surrogate alone. RESULTS: The KIM localisation accuracy was 0.2±0.9 mm (left-right), 0.3±0.6 mm (superior-inferior) and 1.2±0.8 mm (anterior-posterior) for translations and -0.1◦±0.8◦ (left-right), 0.6◦±1.2◦ (superior-inferior) and 0.1◦±0.9◦ (anterior-posterior) for rotations. The cumulative dose to the GTV with KIM + external surrogate was always within 5% of the plan. In 2 out of 15 patients, >5% dose error would have occurred to the GTV and an organ-at-risk with external surrogate alone. CONCLUSIONS: This work demonstrates that real-time 6DoF IGRT for liver can be implemented on standard radiotherapy systems to improve treatment accuracy and safety. The observations made during the treatments highlight the potential false assurance of using traditional external surrogates to assess tumour motion in patients and the need for ongoing improvement of IGRT technologies.

The dosimetric effect of zipper artifacts on tomotherapy adaptive dose calculation--a phantom study.

Tomotherapy adaptive dose calculation offers the ability to verify and adjust the therapeutic plan during the treatment. Using tomotherapy adaptive dose calculation, the planned fluence pattern can be used to recalculate the dose distribution on pretreatment megavoltage computed tomography (MVCT) images. Zipper artifacts, which appear as increased density in the central region of MVCT images, may affect the accuracy of adaptive dose recalculation. The purpose of this study was to evaluate the dosimetric effects of zipper artifacts on tomotherapy adaptive dose calculation. MVCT images of a cylindrical water phantom of 22-cm diameter were acquired on a tomotherapy system. The zipper artifacts were enclosed by a cylindrical planning target volume (PTV) contoured on these images. For comparison, artifact-free images were created by replacing the computed tomography (CT) numbers of zipper artifacts with the mean CT number of water. Treatment plans were generated by giving a uniform dose of 2 Gy to the PTV based on these modified images; it was then applied to the images that have the zipper artifacts. The impacts of different pitch ratios on the artifacts were assessed. The dose distribution differences between the 2 sets of images were compared. The absorbed dose that covered 95% volume of PTV and maximum dose, minimum dose, and mean dose of the PTV were also calculated and compared. The water phantom was scanned on the tomotherapy system twice per week for 12 consecutive weeks. The mean CT number of zipper artifacts (101 HU) was three times higher than that of water (34 HU). The CT number value and location of zipper artifacts were not affected by the pitch ratio. Gamma analysis was performed between the original and recalculated dose distributions. The discrepancies between the isodose distributions calculated by two sets of images were within 1%/1-mm tolerance. The dosimetric impact from zipper artifacts was found insignificant such that the recalculated dose was underestimated by less than 0.5%.